Latest filing published 09 May 2025 for Prestige Consumer Healthcare Inc., €33k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adel Mekhail, listed as senior executive, appears in our data through filings on Prestige Consumer Healthcare Inc. shares, published by SEC (Form 4). Over a trading history stretching from 3 May 2021 to 7 May 2025, the count stands at 20 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 9 May 2025, reports a share grant of €33k in Prestige Consumer Healthcare Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations